anti-ARAF (ARAF) Antikörper

Bezeichnung:: anti-V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog Antikörper (ARAF)

Auf www.antikoerper-online.de finden Sie aktuell 163 V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog (ARAF) Antikörper von 21 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen ARAF Proteine (9) und ARAF Kits (4) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 186 ARAF Produkte verfügbar.

Synonyme:: 1200013E08Rik, A-Raf, araf, Araf1, AW495444, PKS2, RAFA1, wu:fk45h07, zgc:92074

Alle Antikörper anzeigen	Gen	GeneID	UniProt
	ARAF	369	P10398
	ARAF	11836	P04627
	ARAF	64363	P14056
Alle Spezies anzeigen Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-ARAF (ARAF) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human ARAF Antikörper:

anti-Mouse (Murine) ARAF Antikörper:

anti-Rat (Rattus) ARAF Antikörper:

Alle verfügbaren anti-ARAF Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Verknüpfte Pathways mit anti-ARAF Antikörper

Hepatitis C

Weitere Produktkategorien zu ARAF Antikörper

Weitere Antikörper gegen ARAF Interaktionspartner

Zebrafish V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog (ARAF) Interaktionspartner

different isoforms of Araf may participate in similar developmental processes but by regulating different signaling pathways

Human V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog (ARAF) Interaktionspartner

The constitutive or induced re-localization of A-Raf to the plasma membrane compromises its ability to efficiently sequester and inactivate MST2 (zeige STK3 Antikörper), thus rendering cells susceptible to apoptosis
This review discusses the regulation of A-Raf protein (zeige RAF1 Antikörper) expression, and the roles of A-Raf in apoptosis and cancer, with a special focus on its role in resistance to Raf (zeige RAF1 Antikörper) inhibitors. [review]
analysis of FGFR2 (zeige FGFR2 Antikörper)-PPHLN1 (zeige PPHLN1 Antikörper) fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Aberrant expression of A-, B-, and C-RAF (zeige RAF1 Antikörper), and COT (zeige MAP3K8 Antikörper) is frequent in PTC (zeige F9 Antikörper); increased expression of COT (zeige MAP3K8 Antikörper) is correlated with recurrence of PTC (zeige F9 Antikörper).
Dimerization of the kinase ARAF promotes MAPK (zeige MAPK1 Antikörper) pathway activation and cell migration.
The study identifies somatic activating ARAF mutations in Langerhans cell histiocytosis.
Galpha12 (zeige GNA12 Antikörper)-ARAF-ERK (zeige EPHB2 Antikörper) pathway stimulates RFFL (zeige RFFL Antikörper) transcription through the transcription factor c-Myc (zeige MYC Antikörper).
show that Araf antagonizes mesendoderm induction and patterning activity of Nodal/Smad2 (zeige SMAD2 Antikörper) signals in vertebrate embryos by directly inhibiting Smad2 (zeige SMAD2 Antikörper) signalling
study investigated role of ARAF in cancer cell signaling and examined the role of ARAF in mediating paradoxical activation of the MAPK (zeige MAPK1 Antikörper) pathway in cells treated with RAF (zeige RAF1 Antikörper) inhibitors; ARAF seems to stabilize BRAF:CRAF complexes in cells treated with RAF (zeige RAF1 Antikörper) inhibitors and regulate cell signaling in a subtle manner to ensure signaling efficiency
Ras pathway activation via EGF (zeige EGF Antikörper) treatment induced strong binding between B-Raf (zeige SNRPE Antikörper) and C-Raf (zeige RAF1 Antikörper) and a low level of binding between B-Raf (zeige SNRPE Antikörper) and A-Raf.

Mouse (Murine) V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog (ARAF) Interaktionspartner

PKM1 interacts with A-Raf, an upstream regulator of the MEK (zeige MDK Antikörper)/ERK (zeige EPHB2 Antikörper) pathway, and that this interaction contributes to MEK1 (zeige MAP2K1 Antikörper) phosphorylation by A-Raf.
A- and B-Raf (zeige SNRPE Antikörper) ablation in chondrocytes does not alter skeletal development, whereas ablation of C-Raf (zeige RAF1 Antikörper) decreases hypertrophic chondrocyte apoptosis and impairs vascularization of the growth plate. However, ablation of C-Raf (zeige RAF1 Antikörper) does not impair phosphate-induced ERK1/2 phosphorylation in vitro, but leads to rickets by decreasing VEGF (zeige VEGFA Antikörper) protein stability.
A-Raf promotes osteoblasts differentiation in response to mechanical stress.
DA-Raf (zeige RAF1 Antikörper)-dependent inhibition of the Ras-ERK (zeige EPHB2 Antikörper) signaling pathway in alveolar epithelial 2 cells is required for alveolar formation via triggering MMP2 (zeige MMP2 Antikörper) activation followed by myofibroblast differentiation.
Galpha12 (zeige GNA12 Antikörper)-ARAF-ERK (zeige EPHB2 Antikörper) pathway stimulates RFFL (zeige RFFL Antikörper) transcription through the transcription factor c-Myc (zeige MYC Antikörper).
Expression of Araf in the mouse nucleus accumbens is modulated by a sequence variant (B2 SINE indel) in the 3' UTR (zeige UTS2R Antikörper) of Comt (catechol-O-methyltransferase (zeige COMT Antikörper)).
the binding of 14-3-3gamma (zeige YWHAG Antikörper) to Raf (zeige RAF1 Antikörper) indicates the critical role of this protein in ischemia-induced apoptosis and the changes in signal transduction in astrocytes in culture.
Raf-1 (zeige RAF1 Antikörper) and A-Raf have a combined role in controlling physiological transient ERK (zeige EPHB2 Antikörper) activation and in maintenance of cell cycle progression at its usual rate.

ARAF Antigen-Profil

Beschreibung des Gens

This proto-oncogene belongs to the RAF subfamily of the Ser/Thr protein kinase family, and maybe involved in cell growth and development. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with ARAF

A-Raf proto-oncogene, serine/threonine kinase (araf) Antikörper
A-Raf proto-oncogene, serine/threonine kinase (ARAF) Antikörper
A-Raf proto-oncogene, serine/threonine kinase L homeolog (araf.L) Antikörper
A-Raf proto-oncogene, serine/threonine kinase S homeolog (araf.S) Antikörper
Araf proto-oncogene, serine/threonine kinase (Araf) Antikörper
A-Raf proto-oncogene, serine/threonine kinase (Araf) Antikörper

1200013E08Rik Antikörper
A-Raf Antikörper
araf Antikörper
Araf1 Antikörper
AW495444 Antikörper
PKS2 Antikörper
RAFA1 Antikörper
wu:fk45h07 Antikörper
zgc:92074 Antikörper

Bezeichner auf Proteinebene für ARAF

serine/threonine protein kinase ARAF standard form , serine/threonine-protein kinase A-Raf , v-raf murine sarcoma 3611 viral oncogene homolog , v-raf murine sarcoma 3611 viral oncogene-like protein , serine/threonine protein kinase ARAF , serine/threonine-protein kinase A-Raf-like , A-Raf proto-oncogene serine/threonine-protein kinase , Oncogene ARAF1 , Ras-binding protein DA-Raf , proto-oncogene A-Raf-1 , proto-oncogene Pks , v-raf murine sarcoma 3611 viral oncogene homolog 1 , proto-oncogene A-Raf , raf-related oncogene , Raf related protein , Ras-binding protein , v-raf oncogene homolog 1 (murine sarcoma 3611 virus) , A-Raf-1

GENE ID	SPEZIES
403063	Danio rerio
707169	Macaca mulatta
100305131	Ovis aries
100340437	Oryctolagus cuniculus
398892	Xenopus laevis
399056	Xenopus laevis
100387961	Callithrix jacchus
100431871	Pongo abelii
369	Homo sapiens
11836	Mus musculus
64363	Rattus norvegicus
491857	Canis lupus familiaris
397601	Sus scrofa
540421	Bos taurus

Ausgewählte Anbieter für anti-ARAF (ARAF) Antikörper

Haben Sie etwas anderes gesucht?

Telefon:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@antikoerper-online.de